Search Results 131-140 of 9611 for Tuberculous lymphadenitis
Jacksonville, Fla. The purpose of this study is to evaluate Lamprene (Clofazimine) to treat non-tuberculous mycobacterial (NTM) infections. A Prospective ...
Comparison of the QuantiFERON-TB Gold Plus and QuantiFERON-TB Gold In-Tube Interferon Gamma Release Assays in Patients at Risk for Tuberculosis and in Health ...
This uncommon genetic disorder causes tumors that are not cancer. These tumors are unexpected overgrowths of tissue in different parts of the body.
The purpose of this study is to evaluate Lamprene (Clofazimine) to treat non-tuberculous mycobacterial (NTM) infections. A Study To Collect Thoracic Specimens ...
Monoclonal antibodies, such as ipilimumab, can block tumor growth in different ways. Some block the ability of tumor cells to grow and spread. Others find tumor ...
Multicentric Castleman disease (MCD) involves multiple regions of enlarged lymph nodes. It can cause inflammatory symptoms and issues with organ function. There ...
For PMBCL, a biopsy from the mass is taken. The sample is tested in a lab to look for cancer cells. Imaging tests. An imaging test takes pictures inside the ...
document history of a completed course of adequate prophylaxis (completed treatment for latent tuberculosis per local standard of care prior to the start of ...
Patients at risk for tuberculosis (TB) defined as follows: Current clinical, radiographic or laboratory evidence of active TB, even if currently being treated.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Mayo Clinic researchers drive discoveries that improve detection, diagnosis and treatment. Your quick message to them means so much.